Multicenter cross-sectional study of asymptomatic peripheral arterial disease among patients with a single previous coronary or cerebrovascular event in the Arabian Gulf

References

• Steg PG, Bhatt DL, Wilson PW, et al. One-year cardiovascular event rates in outpatients with atherothrombosis. JAMA 2007;297:1197-206
   PubMed Web of Science ®Google Scholar
• Leng GC, Lee AJ, Fowkes FG, et al. Incidence, natural history and cardiovascular events in symptomatic and asymptomatic peripheral arterial disease in the general population. Int J Epidemiol 1996;25:1172-81
   PubMed Web of Science ®Google Scholar
• Criqui MH, Langer RD, Fronek A, et al. Mortality over a period of 10 years in patients with peripheral arterial disease. N Engl J Med 1992;326:381-6
   PubMed Web of Science ®Google Scholar
• Smith GD, Shipley MJ, Rose G. Intermittent claudication, heart disease risk factors, and mortality. The Whitehall Study. Circulation 1990;82:1925-31
   PubMed Web of Science ®Google Scholar
• Selvin E, Erlinger TP. Prevalence of and risk factors for peripheral arterial disease in the United States. Results from the National Health and Nutrition Examination Survey, 1999–2000. Circulation 2004;110:738-43
   PubMed Web of Science ®Google Scholar
• Criqui MH, Fronek A, Barrett-Connor E, et al. The prevalence of peripheral arterial disease in a defined population. Circulation 1985;71:510-15
   PubMed Web of Science ®Google Scholar
• Criqui MH, Denenberg JO, Langer RD, et al. The epidemiology of peripheral arterial disease: importance of identifying the population at risk. Vasc Med 1997;2:221-6
   PubMedGoogle Scholar
• Khandanpour N, Loke YK, Meyer FJ, et al. Homocysteine and peripheral artery disease: systematic reviews and meta-analysis. Eur J Vasc Endovasc Surg 2009;38:316-22
   PubMed Web of Science ®Google Scholar
• Maksimovic M, Vlajinac H, Radak D, et al. Relationship between high-sensitivity C-reactive protein on and risk factors in patients with peripheral arterial disease: a cross-sectional study. Angiology 2013;64:230-6
   PubMed Web of Science ®Google Scholar
• Bashir R, Cooper CJ. Evaluation and medical treatment of peripheral arterial disease. Curr Opin Cardiol 2003;18:436-43
   PubMed Web of Science ®Google Scholar
• Eraso LH, Fukaya E, Mohler ER 3rd, et al. Peripheral artery disease, prevalence and cumulative risk factor profile analysis. Eur J Prev Cardiol 2012 doi: 10.1177/2047487312452968 [Epub ahead of print]
   Google Scholar
• Sander K, Bickel H, Schulze Horn C, et al. Peripheral artery disease: predictors and treatment intensity. Two-years of data from the population-based INVADE project. Dtsch Med Wochenschr 2008;133:455-9
   PubMed Web of Science ®Google Scholar
• Hayoz D, Bounameaux H, Canova CR. Swiss atherothrombosis survey: a filed report on the occurrence of symptomatic and asymptomatic peripheral disease. J Intern Med 2005;258:238-43
   PubMed Web of Science ®Google Scholar
• Kownator S, Cambou JP, Cacoub P, et al. Prevalence of unknown peripheral arterial disease in patients with coronary artery disease: data in primary care from the IPSILON study. Arch Cardiovasc Dis 2009;102:625-31
   PubMed Web of Science ®Google Scholar
• Hoshino H, Itoh Y, Yamada S, Suzuki N. Prevalence and clinical features of asymptomatic peripheral artery disease in Japanese stroke patients. J Stroke Cerebrovasc Dis 2013;22:255-9
   PubMed Web of Science ®Google Scholar
• Bozkurt AK, Tasci T, Tabak O, et al. Peripheral artery disease assessed by ankle-brachial index in patients with established cardiovascular disease or at least one risk factor for atherothrombosis – CAREFUL study: a national, multi-center, cross-sectional observational study. BMC Cardiovasc Disord 2011;11:4
   PubMed Web of Science ®Google Scholar
• Al-Sheikh SO, Aljabri BA, Al-Ansary LA, et al. Prevalence of and risk factors for peripheral arterial disease in Saudi Arabia. A pilot cross-sectional study. Saudi Med J 2007;28:412-14
   PubMed Web of Science ®Google Scholar
• Tavintharan S, Cheung N, Lim SC, et al. Prevalence and risk factors of peripheral artery disease in an Asian population with diabetes mellitus. Diab Vasc Dis Res 2009;6:80-6
   PubMed Web of Science ®Google Scholar
• El-Menyar A, Amin H, Rashdan I, et al. Ankle-brachial index and extent of atherosclerosis in patients from the Middle East (the AGATHA-ME study): a cross-sectional multicenter study. Angiology 2009;60:329-34
   PubMed Web of Science ®Google Scholar
• Al-Thani HA, El-Menyar A, Zubaid M, et al. Peripheral arterial disease in patients presenting with acute coronary syndrome in six Middle Eastern countries. Int J Vasc Med 2011;2011:815902
   PubMedGoogle Scholar
• Al Thani H, El-Menyar A, Alhabib KF, et al. Polyvascular disease in patients presenting with acute coronary syndrome: its predictors and outcomes. Scientific World J 2012;2012:284851
   Web of Science ®Google Scholar
• Al-Thani H, El-Menyar A, Hussein A, et al. Prevalence, predictors, and impact of peripheral arterial disease in hemodialysis patients: a cohort study with a 3-year follow-up. Angiology 2013;64:98-104
   PubMed Web of Science ®Google Scholar
• Diehm C, Allenberg JR, Pittrow D, et al. Mortality and vascular morbidity in older adults with asymptomatic versus symptomatic peripheral artery disease. Circulation 2009;120:2053-61
   PubMed Web of Science ®Google Scholar
• Premalatha G, Shanthirani S, Deepa R, et al. Prevalence and risk factors of peripheral vascular disease in a selected South Indian population: the Chennai Urban Population Study. Diabetes Care 2000;23:1295-300
   PubMed Web of Science ®Google Scholar
• Thomas GN, Critchley JA, Tomlinson B, et al. Peripheral vascular disease in Type 2 diabetic Chinese patients: associations with metabolic indices, concomitant vascular disease and genetic factors. Diabet Med 2003;20:988-95
   PubMed Web of Science ®Google Scholar
• Fowkes FG, Low LP, Tuta S, et al.; AGATHA Investigators. Ankle-brachial index and extent of atherothrombosis in 8891 patients with or at risk of vascular disease: results of the international AGATHA study. Eur Heart J 2006;27:1861-7
   PubMed Web of Science ®Google Scholar
• Price JF, Stewart MC, Douglas AF, et al. Frequency of a low ankle brachial index in the general population by age, sex and deprivation: cross-sectional survey of 28,980 men and women. Eur J Cardiovasc Prev Rehabil 2008;15:370-5
   PubMed Web of Science ®Google Scholar
• Aboyans V, McClelland RL, Allison MA, et al. Lower extremity peripheral artery disease in the absence of traditional risk factors. The Multi-Ethnic Study of Atherosclerosis. Atherosclerosis 2011;214:169-73
   PubMed Web of Science ®Google Scholar
• Allison MA, Criqui MH, McClelland RL, et al. The effect of novel cardiovascular risk factors on the ethnic-specific odds for peripheral arterial disease in the Multi-Ethnic Study of Atherosclerosis. J Am Coll Cardiol 2006;48:1190-7
   PubMed Web of Science ®Google Scholar
• Katsiki N, Papadopoulou SK, Fachantidou AI, et al. Smoking and vascular risk: are all forms of smoking harmful to all types of vascular disease? Public Health 2013;127:435-41
   PubMed Web of Science ®Google Scholar
• Adragao T, Pires A, Branco P, et al. Ankle–brachial index, vascular calcifications and mortality in dialysis patients. Nephrol Dial Transplant 2012;27:318-25
   PubMed Web of Science ®Google Scholar
• Hirsch AT, Criqui MH, Treat-Jacobson D, et al. Peripheral arterial disease detection, awareness, and treatment in primary care. JAMA 2001;286:1317-24
   PubMed Web of Science ®Google Scholar
• Blacher J, Cacoub P, Luizy F, et al. Peripheral arterial disease versus other localizations of vascular disease: the ATTEST study. J Vasc Surg 2006;44:314-18
   PubMed Web of Science ®Google Scholar
• McDermott MM, Mehta S, Ahn H, et al. Atherosclerotic risk factors are less intensively treated in patients with peripheral arterial disease than in patients with coronary artery disease. J Gen Intern Med 1997;12:209-15
   PubMed Web of Science ®Google Scholar
• Anand SS, Kundi A, Eikelboom J, Yusuf S. Low rates of preventive practices in patients with peripheral vascular disease. Can J Cardiol 1999;15:1259-63
   PubMed Web of Science ®Google Scholar
• CAPRIE Steering Committee. A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). Lancet 1996;348:1329-39
   PubMed Web of Science ®Google Scholar
• Heart Protection Study Collaborative Group. MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial. Lancet 2002;360:7-22
   PubMed Web of Science ®Google Scholar
• Yusuf S, Sleight P, Pogue J, et al. Effects of an angiotensin-converting enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators. N Engl J Med 2000;342:145-53
   PubMed Web of Science ®Google Scholar
• Paraskevas KI, Wierzbicki AS, Mikhailidis DP. Statins and noncardiac vascular disease. Curr Opin Cardiol 2012;27:392-7
   PubMed Web of Science ®Google Scholar
• Wong PF, Chong LY, Mikhailidis DP, et al. Antiplatelet agents for intermittent claudication. Cochrane Database Syst Rev 2011;11:CD001272
   Google Scholar
• McDermott MM, Hahn EA, Greenland P, et al. Atherosclerotic risk factor reduction in peripheral arterial disease: results of a national physician survey. J Gen Intern Med 2002;17:895-904
   PubMed Web of Science ®Google Scholar
• United Arab Emirates National Bureau of Statistics 2010. Available at: http://www.uaestatistics.gov.ae/EnglishHome/tabid/96/Default.aspx [Last accessed 22 February 2013]
   Google Scholar